Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,726 Jan 1 – Oct 24, 2026
- Disclosed funding
- $306B 3682 disclosed amounts
- Median round
- $14.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C ConcordCompany profile Automates media buying execution across major ad platforms for global agencies and advertisers Automates media buying execution across major ad platforms for global agencies and advertisers | $3M | Seed | Enterprise software | France | Investors | |
| KR Kunlunxing RoboticsCompany profile Kunlunxing Robotics develops humanoid robots and embodied AI models that connect perception, reasoning and physical action. Kunlunxing Robotics develops humanoid robots and embodied AI models that connect perception, reasoning and physical action. | Undisclosed | Third financingUndisclosed | Robotics | China | Investors Undisclosed | |
| S Makes weaponised drones | €500M | Undisclosed | Defense tech | Germany | Investors | |
| NB NorthLinks BioCompany profile Develops broad-spectrum antiviral prophylactic therapies for respiratory infections Develops broad-spectrum antiviral prophylactic therapies for respiratory infections | $34M | Undisclosed | Biotech | United States | Investors | |
| KR Kunlunxing RoboticsCompany profile Kunlunxing Robotics develops humanoid robots and embodied AI models that connect perception, reasoning and physical action. Kunlunxing Robotics develops humanoid robots and embodied AI models that connect perception, reasoning and physical action. | Undisclosed | First financingUndisclosed | Robotics | China | Investors Undisclosed | |
| OB Osanni BioCompany profile Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model | $190M | Series B | Biotech | United States | Investors | |
AlliumCompany profile Allium provides blockchain data products for institutional research, finance operations and applications that need consistent information across networks. Allium provides blockchain data products for institutional research, finance operations and applications that need consistent information across networks. | $40M | Series B | Fintech | United States | Investors | |
| V VARMCompany profile Trains career changers to become certified insulation installers and deploys them across Europe Trains career changers to become certified insulation installers and deploys them across Europe | €17.5M | Series A | Climate tech | Germany | Investors | |
| UT Ubotica TechnologiesCompany profile Provides real-time maritime intelligence from space using AI-powered analysis Provides real-time maritime intelligence from space using AI-powered analysis | $11M | Undisclosed | Space tech | Ireland | Investors | |
| L LuxSiliconCompany profile LuxSilicon designs silicon-photonics chips and optical engines that connect computing hardware in data centres and high-performance computing systems. LuxSilicon designs silicon-photonics chips and optical engines that connect computing hardware in data centres and high-performance computing systems. | Undisclosed | Angel+Undisclosed | Hardware | China | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Tractian, Legora, Different
101rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
72rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →